Tetsuya Kurosu

1.0k total citations
35 papers, 831 citations indexed

About

Tetsuya Kurosu is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Tetsuya Kurosu has authored 35 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 17 papers in Genetics and 12 papers in Molecular Biology. Recurrent topics in Tetsuya Kurosu's work include Chronic Myeloid Leukemia Treatments (15 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Acute Myeloid Leukemia Research (11 papers). Tetsuya Kurosu is often cited by papers focused on Chronic Myeloid Leukemia Treatments (15 papers), Chronic Lymphocytic Leukemia Research (12 papers) and Acute Myeloid Leukemia Research (11 papers). Tetsuya Kurosu collaborates with scholars based in Japan and United States. Tetsuya Kurosu's co-authors include Osamu Miura, Kazuhiko Kakihana, Gaku Oshikawa, Tohru Miki, Tetsuya Fukuda, Toshikage Nagao, Nan Wu, Masahide Yamamoto, Ayako Arai and Takatoshi Koyama and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Tetsuya Kurosu

33 papers receiving 819 citations

Peers

Tetsuya Kurosu

HEMAT

ONCOL

GENET

IMMUN

Pu Zhang China

Ricardo López‐Pérez Spain

Nathalie Belhacène France

Baohua Sun United States

Cezary Swider United States

Eliza Vakana United States

Sagarika Ray United States

Mark E. Drotar United Kingdom

M Durstin United States

A M Martelli Italy

Pu Zhang China

Tetsuya Kurosu

450 ×1.0

304 ×0.9

HEMAT

199 ×1.1

ONCOL

145 ×0.8

GENET

99 ×1.0

IMMUN

Citations per year, relative to Tetsuya Kurosu Tetsuya Kurosu (= 1×) peers Pu Zhang

Countries citing papers authored by Tetsuya Kurosu

Since Specialization

Citations

This map shows the geographic impact of Tetsuya Kurosu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuya Kurosu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuya Kurosu more than expected).

Fields of papers citing papers by Tetsuya Kurosu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuya Kurosu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuya Kurosu. The network helps show where Tetsuya Kurosu may publish in the future.

Co-authorship network of co-authors of Tetsuya Kurosu

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuya Kurosu. A scholar is included among the top collaborators of Tetsuya Kurosu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuya Kurosu. Tetsuya Kurosu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Umezawa, Yoshihiro, et al.. (2017). Molecular mechanisms for enhancement of stromal cell-derived factor 1–induced chemotaxis by platelet endothelial cell adhesion molecule 1 (PECAM-1). Journal of Biological Chemistry. 292(48). 19639–19655. 7 indexed citations

Yamamoto, Masahide, et al.. (2014). Evaluation of the efficacy of maintenance therapy for low-to-intermediate-risk acute promyelocytic leukemia in molecular remission: A retrospective single-institution study. Molecular and Clinical Oncology. 3(2). 449–453. 3 indexed citations

Nagao, Toshikage, Tetsuya Kurosu, Yoshihiro Umezawa, et al.. (2014). Proliferation and Survival Signaling from Both Jak2-V617F and Lyn Involving GSK3 and mTOR/p70S6K/4EBP1 in PVTL-1 Cell Line Newly Established from Acute Myeloid Leukemia Transformed from Polycythemia Vera. PLoS ONE. 9(1). e84746–e84746. 24 indexed citations

Kurosu, Tetsuya, Toshikage Nagao, Nan Wu, Gaku Oshikawa, & Osamu Miura. (2013). Inhibition of the PI3K/Akt/GSK3 Pathway Downstream of BCR/ABL, Jak2-V617F, or FLT3-ITD Downregulates DNA Damage-Induced Chk1 Activation as Well as G2/M Arrest and Prominently Enhances Induction of Apoptosis. PLoS ONE. 8(11). e79478–e79478. 32 indexed citations

Wu, Nan, Tetsuya Kurosu, Gaku Oshikawa, Toshikage Nagao, & Osamu Miura. (2012). PECAM-1 is involved in BCR/ABL signaling and may downregulate imatinib-induced apoptosis of Philadelphia chromosome-positive leukemia cells. International Journal of Oncology. 42(2). 419–428. 7 indexed citations

Oshikawa, Gaku, Toshikage Nagao, Nan Wu, Tetsuya Kurosu, & Osamu Miura. (2011). c-Cbl and Cbl-b Ligases Mediate 17-Allylaminodemethoxygeldanamycin-induced Degradation of Autophosphorylated Flt3 Kinase with Internal Tandem Duplication through the Ubiquitin Proteasome Pathway. Journal of Biological Chemistry. 286(35). 30263–30273. 38 indexed citations

Nagao, Toshikage, Gaku Oshikawa, Nan Wu, Tetsuya Kurosu, & Osamu Miura. (2011). DNA Damage Stress and Inhibition of Jak2-V617F Cause Its Degradation and Synergistically Induce Apoptosis through Activation of GSK3β. PLoS ONE. 6(11). e27397–e27397. 15 indexed citations

Oshikawa, Gaku, Tetsuya Kurosu, Ayako Arai, Naomi Murakami, & Osamu Miura. (2010). Clonal evolution with double Ph followed by tetraploidy in imatinib-treated chronic myeloid leukemia with e19a2 transcript in transformation. Cancer Genetics and Cytogenetics. 199(1). 56–61. 8 indexed citations

Kakihana, Kazuhiko, et al.. (2008). A novel variant form of MLL-ELL fusion transcript with t(11;19)(q23;p13.1) in chronic myelomonocytic leukemia transforming to acute myeloid leukemia. Cancer Genetics and Cytogenetics. 184(2). 109–112. 8 indexed citations

10.

Kurosu, Tetsuya, Tohru Miki, Masahide Yamamoto, et al.. (2008). A variant-type MLL/SEPT9 fusion transcript in adult de novo acute monocytic leukemia (M5b) with t(11;17)(q23;q25). International Journal of Hematology. 88(2). 192–196. 17 indexed citations

11.

Teng, Yuou, Yusuke Takahashi, Makiko Yamada, et al.. (2007). IRF4 negatively regulates proliferation of germinal center B cell-derived Burkitt's lymphoma cell lines and induces differentiation toward plasma cells. European Journal of Cell Biology. 86(10). 581–589. 30 indexed citations

12.

Kakihana, Kazuhiko, et al.. (2007). Glycogen synthase kinase-3β and p38 phosphorylate cyclin D2 on Thr280 to trigger its ubiquitin/proteasome-dependent degradation in hematopoietic cells. Oncogene. 26(46). 6630–6640. 46 indexed citations

13.

Kurosu, Tetsuya, et al.. (2006). Rottlerin synergistically enhances imatinib-induced apoptosis of BCR/ABL-expressing cells through its mitochondrial uncoupling effect independent of protein kinase C-δ. Oncogene. 26(21). 2975–2987. 30 indexed citations

14.

Kurosu, Tetsuya, Yusuke Takahashi, Tetsuya Fukuda, et al.. (2005). p38 MAP kinase plays a role in G2 checkpoint activation and inhibits apoptosis of human B cell lymphoma cells treated with etoposide. APOPTOSIS. 10(5). 1111–1120. 38 indexed citations

15.

Yamamoto, Masahide, Kazuhiko Kakihana, Tetsuya Kurosu, Naomi Murakami, & Osamu Miura. (2005). Clonal evolution with inv(11)(p15q22) and NUP98/DDX10 fusion gene in imatinib-resistant chronic myelogenous leukemia. Cancer Genetics and Cytogenetics. 157(2). 104–108. 25 indexed citations

16.

Hosoda, Saichi, Yoshihiro Ishikawa, Tomoko Hasunuma, et al.. (2004). Effects of Colforsin Daropate Hydrochloride (Adehl Inj.), Anti-Acute Heart Failure Agent, on Adenylate Cyclase-Related Hormone Actions. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 35(5). 235–246.

17.

Yamamoto, Masahide, et al.. (2004). The two major imatinib resistance mutations E255K and T315I enhance the activity of BCR/ABL fusion kinase. Biochemical and Biophysical Research Communications. 319(4). 1272–1275. 47 indexed citations

18.

Kurosu, Tetsuya, et al.. (2004). BCR/ABL activates Rap1 and B-Raf to stimulate the MEK/Erk signaling pathway in hematopoietic cells. Biochemical and Biophysical Research Communications. 326(3). 645–651. 36 indexed citations

19.

Kurosu, Tetsuya, Tetsuya Fukuda, Tohru Miki, & Osamu Miura. (2003). BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells. Oncogene. 22(29). 4459–4468. 89 indexed citations

20.

Saitô, Takako, Tetsuya Kurosu, Koh Yamamoto, et al.. (1998). Two M‐components in a single cell lineage in a patient with a dual isotype secretory B‐cell tumour. British Journal of Haematology. 102(3). 791–794. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact